CTI Biopharma Corp CTIC:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/27/21 EDT
3.11quote price arrow up+0.01 (+0.32%)
Volume
16,006
Close
3.10quote price arrow up+0.06 (+1.97%)
Volume
499,358
52 week range
1.02 - 4.13
Loading...
  • Open3.03
  • Day High3.12
  • Day Low3.03
  • Prev Close3.10
  • 52 Week High4.13
  • 52 Week High Date03/22/21
  • 52 Week Low1.02
  • 52 Week Low Date09/29/20

Key Stats

  • Market Cap289.26M
  • Shares Out93.31M
  • 10 Day Average Volume0.58M
  • Dividend-
  • Dividend Yield-
  • Beta0.76
  • YTD % Change-3.73

KEY STATS

  • Open3.03
  • Day High3.12
  • Day Low3.03
  • Prev Close3.10
  • 52 Week High4.13
  • 52 Week High Date03/22/21
  • 52 Week Low1.02
  • 52 Week Low Date09/29/20
  • Market Cap289.26M
  • Shares Out93.31M
  • 10 Day Average Volume0.58M
  • Dividend-
  • Dividend Yield-
  • Beta0.76
  • YTD % Change-3.73

RATIOS/PROFITABILITY

  • EPS (TTM)-0.80
  • P/E (TTM)-3.89
  • Fwd P/E (NTM)-6.01
  • EBITDA (MRQ)-61.889M
  • ROE (MRQ)-106.61%
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)80.74%
  • Net Margin (MRQ)-1,940.54%
  • Debt To Equity (MRQ)3.32%

EVENTS

  • Earnings Date11/08/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On CTI Biopharma Corp

There is no recent news for this security.

Profile

MORE
CTI BioPharma Corp. is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers to patients and healthcare providers. The Company is primarily focused on commercializing PIXUVRI in select countries in the European Union, for multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (NHL). It is also engaged in evaluating pacritinib for the treatment of adult...
Laurent Fischer M.D.
Non-Executive Chairman
Adam Craig M.D., Ph.D.
President
Bruce Seeley
Chief Operating Officer
David Kirske
Chief Financial Officer
Address
3101 Western Ave Ste 800
Seattle, WA
98121-3017
United States

Top Peers

SYMBOLLASTCHG%CHG
CRVS
Corvus Pharmaceuticals Inc
7.67+0.87+12.79%
CKPT
Checkpoint Therapeutics Inc
3.53+0.16+4.75%
SRRA
Sierra Oncology Inc
22.56+0.11+0.49%
CRDF
Cardiff Oncology Inc
7.39+0.03+0.41%
CABA
Cabaletta Bio Inc
12.48+0.47+3.91%